From: Exploring autism symptoms in an Australian cohort of patients with Prader-Willi and Angelman syndromes
PWS
AS
Medication use
Growth hormone
68.0%
0%
Anticonvulsant
8.0%
73.7%
Genetic subtype
Deletion
24.0%
47.4%
UPD
64.0%
15.8%
Imprinting centre defect
Abnormal methylationa
4.0%
5.2%
UBE3A mutation
NA
31.6%